Expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 after administration of endotoxin in diabetic rats

Tuberculosis and Respiratory Diseases

Volumn 61, Issue 3, 2006, Pages 256-264

  Seo, Ki Hyun ^a   Choi, Jae Sung ^a   Na, Joo Ok ^a   Uh, Soo Taek ^a   Kim, Yong Hoon ^a,b   Park, Choon Sik ^a  

^a Soonchunhyang University College of Medicine   (South Korea)

^b Soonchunhyang University   (South Korea)

Author keywords

Diabetes; LPS (lipopolysaccharide); MMP 9 (matrix metalloproteinase 9); TIMP 1 (tissue inhibitor of metalloproteinase 1)

Indexed keywords

ENDOGENOUS COMPOUND; ENDOTOXIN; GELATINASE B; LIPOPOLYSACCHARIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; LUNG LAVAGE; MALE; NONHUMAN; RAT; WESTERN BLOTTING;

EID: 33845345223     PISSN: 17383536     EISSN: None     Source Type: Journal    
DOI: 10.4046/trd.2006.61.3.256     Document Type: Article

References (32)

1. Hanley ME, Repine JE. Pathogenesis aspects of the adult respiratory distress syndrome. Semin Respir Crit Care Med 1994;15:260-70.
2. Holter JF, Weiland JE, Patcht ER, Gadek JE, Davis WB. Protein permeability in the adult respiratory distress syndrome: loss of size selectivity of the alveolar epithelium. J Clin Invest 1986;78:1513-22.
3. Simon RH, DeHart PD, Todd RF 3rd. Neutrophilinduced injury of rat pulmonary alveolar epithelial cells. J Clin Invest 1986;78:1375-86.
4. Smedly LA, Tonnesen MG, Sandhaus RA, Haslett C, Guthrie LA, Johnston RB Jr, et al. Neutrophil-mediated injury to endothelial cells: enhancement by endotoxin and essential role of neutrophil elastase. J Clin Invest 1986;77:1233-43.
5. Katzenstein AL, Bloor CM, Liebow AA. Diffuse alveoar damage: the role of oxygen, shock and related factors. Am J Pathol 1976;85:209-28.
6. Palmgren MS, deShazo RD, Carter RM, Zimny ML, Shah SV. Mechanisms of neutrophil damage to human alveolar extracelluar matrix: the role of serine and metalloproteinases. J Allergy Clin Immunol 1992;89:905-15.
7. Shapiro SD, Senior RM. Matrix metalloproteinases: matrix degradation and more. Am J Respir Cell Mol Biol 1999;20:1100-2.
8. Matute-Bello G, Liles WC, Radella F 2nd, Steinberg KP, Ruzinski JT, Jonas M, et al. Neutrophil apoptosis in the acute respiratory distress syndrome. Am J Respir Crit Care Med 1997;156:1969-77.
9. van den Steen PE, Proost P, Wuyts A, van Damme J, Opdenakker G. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood 2000;96:2673-81.
10. Gibbs DF, Shanley TP, Warner RL, Murphy HS, Varani J, Johnson KJ. Role of matrix metalloproteinases in models of macrophage-dependent acute lung injury: evidence for alveolar macrophage as source of proteinases. Am J Respir Cell Mol Biol 1999;20:1145-54.
11. Atkinson JJ, Senior RM. Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol 2003;28:12-24.
12. Stetler-Stevenson WG. Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am J Pathol 1996;148:1345-50.
13. Lanchou J, Corbel M, Tanguy M, Germain N, Boichot E, Theret N, et al. Imbalance between matrix metalloproteinases(MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases(TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients. Crit Care Med 2003;31:536-42.
14. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med 1999;341:1906-12.
15. Lippmann ML, Goldberg SK, Walkenstein MD, Herring W, Gordon M. Bacteremic pneumococcal pneumonia: a community hospital experience. Chest 1995;108:1608-13.
16. Chen KY, Hsueh PR, Liaw YS, Yang PC, Luh KT. A 10-year experience with bacteriology of acute thoracic empyema. Chest 2000;117:1685-9.
17. Bashar M, Alcabes P, Rom WN, Condos R. Increased incidence of multidrug-resistant tuberculosis in diabetic patients on the Bellevue chest service, 1987 to 1997. Chest 2001;120:1514-9.
18. Goldman MD. Lung dysfunction in diabetes. Diabetes Care 2003;26:1915-8.
19. Becher G, Winsel K, Beck E, Neubauer G, Stresemann E. Breath condensate as a method of noninvasive assessment of inflammation mediators from the lower airways. Pneumologie 1997;51(Suppl 2):456-9.
20. Enomoto T, Usuki J, Azuma A, Nakagawa T, Kudoh S. Diabetes mellitus may increase risk for idiopathic pulmonary fibrosis. Chest 2003;123;2007-11.
21. Marhoffer W, Stein M, Maeser E, Federlin K. Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care 1992;15:256-60.
22. Shah SV, Wallin JD, Eilen SD. Chemiluminescence and superoxide anion production by leukocytes from diabetic patients. J Clin Endocrinol Metab 1983;57:402-9.
23. Anderson B, Goldsmith GH, Spagnuolo PJ. Neutrophil adhesive dysfunction in diabetes mellitus: the role of cellular and plasma factors. J Lab Clin Med 1988;111:275-85.
24. Delamaire M, Maugendre D, Moreno M, le Goff MC, Allannic H, Genetet B. Impaired leukocyte functions in diabetic patients. Diabet Med 1997;14:29-34.
25. Dandona P, Aljada A, Mohanty P, Ghanim H, Bandyopadhyay A, Chaudhuri A. Insulin suppresses plasma concentration of vascular endothelial growth factor and matrix metalloproteinase-9. Diabetes Care 2003;26:3310-4.
26. Death AK, Fisher EJ, McGrath KC, Yue DK. High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes. Atherosclerosis 2003;168:263-9.
27. Lee YC, Lee HB, Rhee YK, Song CH. The involvement of matrix metalloproteinase-9 in airway inflammation of patients with acute asthma. Clin Exp Allergy 2001;31:1623-30.
28. Hayashi T, Stetler-Stevenson WG, Fleming MV, Fishback N, Koss MN, Liotta LA, et al. Immunohistochemical study of metalloproteinases and their tissue inhibitor in lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. Am J Pathol 1996;149:1241-56.
29. Ricou B, Nicod L, Lacraz S, Welgus HG, Suter PM, Dayer JM. Matrix metalloproteinases and TIMP in acute respiratory distress syndrome. Am J Respir Crit Care Med 1996;154:346-52.
30. Finlay GA, O'Driscoll LR, Russell KJ, D'Arcy EM, Masterson JB, FitzGerald MX, et al. Matrix metalloproteinases expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med 1997;156:240-7.
31. Gunther A, Walmrath D, Grimminger F, Seeger W. Pathophysiology of acute lung injury. Semin Respir Crit Care Med 2001;22:247-58.
32. Pecsvarady Z, Fisher TC, Darwin CH, Fabok A, Maqueda TS, Saad MF, et al. Decreased polymorphonuclear leukocyte deformability in NIDDM. Diabetes Care 1994;17:57-63.